Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Cost-effective reduction of micro pollutants in the water cycle - Case study on iodinated contrast media.

Strehl C, Thoene V, Heymann L, Schwesig D, Boergers A, Bloser M, Fligge F, Merkel W, Tuerk J.

Sci Total Environ. 2019 Jun 13;688:10-17. doi: 10.1016/j.scitotenv.2019.06.187. [Epub ahead of print]

PMID:
31229807
2.

The deubiquitination of the PTS1-import receptor Pex5p is required for peroxisomal matrix protein import.

El Magraoui F, Brinkmeier R, Mastalski T, Hupperich A, Strehl C, Schwerter D, Girzalsky W, Meyer HE, Warscheid B, Erdmann R, Platta HW.

Biochim Biophys Acta Mol Cell Res. 2019 Feb;1866(2):199-213. doi: 10.1016/j.bbamcr.2018.11.002. Epub 2018 Nov 6.

PMID:
30408545
3.

CTLA-4 Mediates Inhibitory Function of Mesenchymal Stem/Stromal Cells.

Gaber T, Schönbeck K, Hoff H, Tran CL, Strehl C, Lang A, Ohrndorf S, Pfeiffenberger M, Röhner E, Matziolis G, Burmester GR, Buttgereit F, Hoff P.

Int J Mol Sci. 2018 Aug 7;19(8). pii: E2312. doi: 10.3390/ijms19082312.

4.

Unraveling the role of hypoxia-inducible factor (HIF)-1α and HIF-2α in the adaption process of human microvascular endothelial cells (HMEC-1) to hypoxia: Redundant HIF-dependent regulation of macrophage migration inhibitory factor.

Hahne M, Schumann P, Mursell M, Strehl C, Hoff P, Buttgereit F, Gaber T.

Microvasc Res. 2018 Mar;116:34-44. doi: 10.1016/j.mvr.2017.09.004. Epub 2017 Oct 6.

PMID:
28993199
5.

Will we ever have better glucocorticoids?

Buttgereit F, Bijlsma JWJ, Strehl C.

Clin Immunol. 2018 Jan;186:64-66. doi: 10.1016/j.clim.2017.07.023. Epub 2017 Jul 27.

PMID:
28757452
6.

Metabolic regulation of inflammation.

Gaber T, Strehl C, Buttgereit F.

Nat Rev Rheumatol. 2017 May;13(5):267-279. doi: 10.1038/nrrheum.2017.37. Epub 2017 Mar 23. Review.

PMID:
28331208
7.

A Pronounced Inflammatory Activity Characterizes the Early Fracture Healing Phase in Immunologically Restricted Patients.

Hoff P, Gaber T, Strehl C, Jakstadt M, Hoff H, Schmidt-Bleek K, Lang A, Röhner E, Huscher D, Matziolis G, Burmester GR, Schmidmaier G, Perka C, Duda GN, Buttgereit F.

Int J Mol Sci. 2017 Mar 8;18(3). pii: E583. doi: 10.3390/ijms18030583.

8.

Glucocorticoid-targeted therapies for the treatment of rheumatoid arthritis.

Strehl C, van der Goes MC, Bijlsma JW, Jacobs JW, Buttgereit F.

Expert Opin Investig Drugs. 2017 Feb;26(2):187-195. doi: 10.1080/13543784.2017.1276562. Epub 2017 Jan 3. Review.

PMID:
28043173
9.

Modification of the surface of superparamagnetic iron oxide nanoparticles to enable their safe application in humans.

Strehl C, Maurizi L, Gaber T, Hoff P, Broschard T, Poole AR, Hofmann H, Buttgereit F.

Int J Nanomedicine. 2016 Nov 8;11:5883-5896. eCollection 2016.

10.

Can adverse effects of glucocorticoid therapy be prevented and treated?

van der Goes MC, Strehl C, Buttgereit F, Bijlsma JW, Jacobs JW.

Expert Opin Pharmacother. 2016 Nov;17(16):2129-2133. Epub 2016 Sep 20. No abstract available.

PMID:
27590884
11.

Immunological characterization of the early human fracture hematoma.

Hoff P, Gaber T, Strehl C, Schmidt-Bleek K, Lang A, Huscher D, Burmester GR, Schmidmaier G, Perka C, Duda GN, Buttgereit F.

Immunol Res. 2016 Dec;64(5-6):1195-1206.

PMID:
27629117
12.

[Long-term glucocorticoid therapy : Is there a safe dosage?].

Strehl C, Buttgereit F.

Internist (Berl). 2016 Sep;57(9):934-9. doi: 10.1007/s00108-016-0098-7. Review. German.

PMID:
27351788
13.

Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force.

Strehl C, Bijlsma JW, de Wit M, Boers M, Caeyers N, Cutolo M, Dasgupta B, Dixon WG, Geenen R, Huizinga TW, Kent A, de Thurah AL, Listing J, Mariette X, Ray DW, Scherer HU, Seror R, Spies CM, Tarp S, Wiek D, Winthrop KL, Buttgereit F.

Ann Rheum Dis. 2016 Jun;75(6):952-7. doi: 10.1136/annrheumdis-2015-208916. Epub 2016 Mar 1. Review.

PMID:
26933146
14.

Effects of PVA-coated nanoparticles on human T helper cell activity.

Strehl C, Schellmann S, Maurizi L, Hofmann-Amtenbrink M, Häupl T, Hofmann H, Buttgereit F, Gaber T.

Toxicol Lett. 2016 Mar 14;245:52-8. doi: 10.1016/j.toxlet.2016.01.003. Epub 2016 Jan 13.

PMID:
26774940
15.

Disentangling the effects of tocilizumab on neutrophil survival and function.

Gaber T, Hahne M, Strehl C, Hoff P, Dörffel Y, Feist E, Burmester GR, Buttgereit F.

Immunol Res. 2016 Jun;64(3):665-76. doi: 10.1007/s12026-015-8770-x.

PMID:
26721805
16.

Monitoring pharmacologically induced immunosuppression by immune repertoire sequencing to detect acute allograft rejection in heart transplant patients: a proof-of-concept diagnostic accuracy study.

Vollmers C, De Vlaminck I, Valantine HA, Penland L, Luikart H, Strehl C, Cohen G, Khush KK, Quake SR.

PLoS Med. 2015 Oct 14;12(10):e1001890. doi: 10.1371/journal.pmed.1001890. eCollection 2015 Oct.

17.

Noninvasive monitoring of infection and rejection after lung transplantation.

De Vlaminck I, Martin L, Kertesz M, Patel K, Kowarsky M, Strehl C, Cohen G, Luikart H, Neff NF, Okamoto J, Nicolls MR, Cornfield D, Weill D, Valantine H, Khush KK, Quake SR.

Proc Natl Acad Sci U S A. 2015 Oct 27;112(43):13336-41. doi: 10.1073/pnas.1517494112. Epub 2015 Oct 12.

18.

Effects of PVA coated nanoparticles on human immune cells.

Strehl C, Gaber T, Maurizi L, Hahne M, Rauch R, Hoff P, Häupl T, Hofmann-Amtenbrink M, Poole AR, Hofmann H, Buttgereit F.

Int J Nanomedicine. 2015 May 8;10:3429-45. doi: 10.2147/IJN.S75936. eCollection 2015.

19.

Circadian rhythms of cellular immunity in rheumatoid arthritis: a hypothesis-generating study.

Spies CM, Hoff P, Mazuch J, Gaber T, Maier B, Strehl C, Hahne M, Jakstadt M, Huscher D, Burmester GR, Detert J, Kramer A, Buttgereit F.

Clin Exp Rheumatol. 2015 Jan-Feb;33(1):34-43. Epub 2014 Dec 22.

PMID:
25535886
20.

Cellular energy metabolism in T-lymphocytes.

Gaber T, Strehl C, Sawitzki B, Hoff P, Buttgereit F.

Int Rev Immunol. 2015 Jan;34(1):34-49. doi: 10.3109/08830185.2014.956358. Epub 2014 Sep 26. Review.

PMID:
25259409
21.

Circulating cell-free DNA enables noninvasive diagnosis of heart transplant rejection.

De Vlaminck I, Valantine HA, Snyder TM, Strehl C, Cohen G, Luikart H, Neff NF, Okamoto J, Bernstein D, Weisshaar D, Quake SR, Khush KK.

Sci Transl Med. 2014 Jun 18;6(241):241ra77. doi: 10.1126/scitranslmed.3007803.

22.

Unraveling the functions of the membrane-bound glucocorticoid receptors: first clues on origin and functional activity.

Strehl C, Buttgereit F.

Ann N Y Acad Sci. 2014 May;1318:1-6. doi: 10.1111/nyas.12364. Epub 2014 Feb 25.

PMID:
24611742
23.

Temporal response of the human virome to immunosuppression and antiviral therapy.

De Vlaminck I, Khush KK, Strehl C, Kohli B, Luikart H, Neff NF, Okamoto J, Snyder TM, Cornfield DN, Nicolls MR, Weill D, Bernstein D, Valantine HA, Quake SR.

Cell. 2013 Nov 21;155(5):1178-87. doi: 10.1016/j.cell.2013.10.034.

24.

Hypoxia: how does the monocyte-macrophage system respond to changes in oxygen availability?

Strehl C, Fangradt M, Fearon U, Gaber T, Buttgereit F, Veale DJ.

J Leukoc Biol. 2014 Feb;95(2):233-41. doi: 10.1189/jlb.1212627. Epub 2013 Oct 29. Review.

PMID:
24168857
25.

Preoperative irradiation for the prevention of heterotopic ossification induces local inflammation in humans.

Hoff P, Rakow A, Gaber T, Hahne M, Sentürk U, Strehl C, Fangradt M, Schmidt-Bleek K, Huscher D, Winkler T, Matziolis D, Matziolis G, Badakhshi H, Burmester GR, Duda GN, Perka C, Buttgereit F.

Bone. 2013 Jul;55(1):93-101. doi: 10.1016/j.bone.2013.03.020. Epub 2013 Apr 6.

PMID:
23571050
26.

Pathophysiological hypoxia affects the redox state and IL-2 signalling of human CD4+ T cells and concomitantly impairs survival and proliferation.

Gaber T, Tran CL, Schellmann S, Hahne M, Strehl C, Hoff P, Radbruch A, Burmester GR, Buttgereit F.

Eur J Immunol. 2013 Jun;43(6):1588-97. doi: 10.1002/eji.201242754. Epub 2013 May 17.

27.

High-sensitivity immunofluorescence staining: a comparison of the liposome procedure and the FASER technique on mGR detection.

Strehl C, Gaber T, Jakstadt M, Hahne M, Hoff P, Spies CM, Scheffold A, Burmester GR, Buttgereit F.

J Fluoresc. 2013 May;23(3):509-18. doi: 10.1007/s10895-013-1163-4. Epub 2013 Feb 14.

PMID:
23408089
28.

Optimized glucocorticoid therapy: teaching old drugs new tricks.

Strehl C, Buttgereit F.

Mol Cell Endocrinol. 2013 Nov 5;380(1-2):32-40. doi: 10.1016/j.mce.2013.01.026. Epub 2013 Feb 8. Review.

PMID:
23403055
29.

Hypoxia promotes osteogenesis but suppresses adipogenesis of human mesenchymal stromal cells in a hypoxia-inducible factor-1 dependent manner.

Wagegg M, Gaber T, Lohanatha FL, Hahne M, Strehl C, Fangradt M, Tran CL, Schönbeck K, Hoff P, Ode A, Perka C, Duda GN, Buttgereit F.

PLoS One. 2012;7(9):e46483. doi: 10.1371/journal.pone.0046483. Epub 2012 Sep 27.

30.

Human monocytes and macrophages differ in their mechanisms of adaptation to hypoxia.

Fangradt M, Hahne M, Gaber T, Strehl C, Rauch R, Hoff P, Löhning M, Burmester GR, Buttgereit F.

Arthritis Res Ther. 2012 Aug 7;14(4):R181. doi: 10.1186/ar4011.

31.

Glucocorticoids.

Spies CM, Strehl C, van der Goes MC, Bijlsma JW, Buttgereit F.

Best Pract Res Clin Rheumatol. 2011 Dec;25(6):891-900. doi: 10.1016/j.berh.2011.11.002. Review.

PMID:
22265268
32.

Pharmacodynamics of glucocorticoids.

Strehl C, Spies CM, Buttgereit F.

Clin Exp Rheumatol. 2011 Sep-Oct;29(5 Suppl 68):S13-8. Epub 2011 Oct 21. Review.

PMID:
22018178
33.

Origin and functional activity of the membrane-bound glucocorticoid receptor.

Strehl C, Gaber T, Löwenberg M, Hommes DW, Verhaar AP, Schellmann S, Hahne M, Fangradt M, Wagegg M, Hoff P, Scheffold A, Spies CM, Burmester GR, Buttgereit F.

Arthritis Rheum. 2011 Dec;63(12):3779-88. doi: 10.1002/art.30637.

34.

Distribution and evolution of genetic caste determination in Pogonomyrmex seed-harvester ants.

Anderson KE, Gadau J, Mott BM, Johnson RA, Altamirano A, Strehl C, Fewell JH.

Ecology. 2006 Sep;87(9):2171-84.

PMID:
16995616
35.
36.

[Lay help in rehabilitation of psychiatrically handicapped patients--report of two comparative empirical studies].

Brackhane R, Strehl C, Wurzer I.

Rehabilitation (Stuttg). 1990 Nov;29(4):254-60. German.

PMID:
2291029
37.

Effects of superabundant food on breeding success and behavior of the red-winged blackbird.

Strehl CE, White J.

Oecologia. 1986 Sep;70(2):178-186. doi: 10.1007/BF00379237.

PMID:
28311655
38.

[Advanced abdominal pregnancy with a live fetus].

Strehl C, Krieger AM, Babiarz JZ, Wawrzków J.

Ginekol Pol. 1984 Feb;55(2):147-50. Polish. No abstract available.

PMID:
6469034
39.

[Sialorrhea in pregnancy].

Strehl C, Szczodrowski J, Wawrzków J.

Wiad Lek. 1980 Oct 15;33(20):1677-9. Polish. No abstract available.

PMID:
7222680
40.

[Hodgkin's disease in pregnancy].

Strehl C, Debniak B, Gruszka K.

Wiad Lek. 1977 Jul 1;30(13):1057-9. Polish. No abstract available.

PMID:
898966
41.

[Pregnancy and labor in adolescents].

Majchrzak R, Michalowski M, Strehl C.

Pol Tyg Lek. 1966 Apr 4;21(14):509-11. Polish. No abstract available.

PMID:
5943735
42.

EVALUATION OF A THREE-YEAR GROUP THERAPY PROGRAM FOR MULTIPLE SCLEROSIS PATIENTS.

MALLY MA, STREHL CB.

Int J Group Psychother. 1963 Jul;13:328-34. No abstract available.

PMID:
14067838
43.

A short survey of blind welfare in Germany.

STREHL C.

Br J Phys Med. 1954 Nov;17(11):256-60. No abstract available.

PMID:
13208979
44.

[Remembering Louis Braille - on the occasion of the 100th anniversary of his death].

STREHL C.

Klin Monbl Augenheilkd Augenarztl Fortbild. 1952;121(1):90-2. German. No abstract available.

PMID:
14946926
45.

Die Entwicklung des deutschen Blindenwesens.

STREHL C.

Grenzgeb Med. 1948 Jun;1(2):50-7. Undetermined Language. No abstract available.

PMID:
18879255

Supplemental Content

Loading ...
Support Center